Cargando…
Rectal Neuroendocrine Tumor G1 with a Solitary Hepatic Metastatic Lesion
Rectal neuroendocrine tumor (NET) is a relatively rare tumor. NET is classified as G1, G2, or G3 according to the degree of mitosis or Ki-67 proliferation index, which reflect the malignant potential of the tumor, such as metastasis. Advanced cases with metastasis are indicated for chemotherapy trea...
Autores principales: | Nagata, Kohei, Tajiri, Kazuto, Shimada, Seitarou, Ando, Takayuki, Hosokawa, Ayumu, Matsui, Koshi, Imura, Joji, Sugiyama, Toshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348452/ https://www.ncbi.nlm.nih.gov/pubmed/28154272 |
Ejemplares similares
-
Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
por: Ando, Takayuki, et al.
Publicado: (2015) -
Peritumoral Hyperplasia in Hepatic Sclerosed Hemangioma
por: Shimada, Seitarou, et al.
Publicado: (2017) -
Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial
por: Ueda, Akira, et al.
Publicado: (2013) -
Neuroendocrine Carcinoma of the Stomach: A Response to Combination Chemotherapy Consisting of Ramucirumab Plus Paclitaxel
por: Matsubara, Yuki, et al.
Publicado: (2017) -
Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir
por: Baba, Hayato, et al.
Publicado: (2016)